申请人:——
公开号:US20030060459A1
公开(公告)日:2003-03-27
The present application describes modulators of MCP-1 of formula (I):
1
or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
本申请描述了公式(I)的MCP-1调节剂或其药用盐形式,用于预防哮喘、多发性硬化症、动脉粥样硬化和类风湿性关节炎。